Cindy Motz
Stock Analyst at Goldman Sachs
(n/a)
# 4,565
Out of 4,947 analysts
14
Total ratings
8.33%
Success rate
-30%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cindy Motz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Upgrades: Neutral | $64 → $77 | $89.89 | -14.34% | 3 | Oct 21, 2022 | |
| HCAT Health Catalyst | Maintains: Buy | $29 → $18 | $2.92 | +516.44% | 5 | Aug 10, 2022 | |
| DOCS Doximity | Maintains: Buy | $53 → $46 | $65.13 | -29.37% | 3 | Aug 8, 2022 | |
| TDOC Teladoc Health | Downgrades: Neutral | $55 → $36 | $7.52 | +378.72% | 3 | Jul 28, 2022 |
HealthEquity
Oct 21, 2022
Upgrades: Neutral
Price Target: $64 → $77
Current: $89.89
Upside: -14.34%
Health Catalyst
Aug 10, 2022
Maintains: Buy
Price Target: $29 → $18
Current: $2.92
Upside: +516.44%
Doximity
Aug 8, 2022
Maintains: Buy
Price Target: $53 → $46
Current: $65.13
Upside: -29.37%
Teladoc Health
Jul 28, 2022
Downgrades: Neutral
Price Target: $55 → $36
Current: $7.52
Upside: +378.72%